UncategorizedAlaska Senate Panel Advances Proposal for Psychedelic-Assisted Treatment Task Force After Adopting Modifications to Align with House Bill February 19, 2024 by Ben Adlin
UncategorizedHawaii Panel Advances Therapeutic Pilocybin Bill that Would Protect Patients from Penalties February 19, 2024 by Ben Adlin
UncategorizedCompare the differences between Virginia’s competing marijuana sales bills on licensing, equity, taxes and more February 19, 2024 by Ben Adlin
UncategorizedThe new FDA report highlights how the marijuana rescheduling review analyzed cannabis users’ social media posts February 19, 2024 by Kyle Jaeger
UncategorizedThe VP Harris reaches out to recipients of cannabis pardons (Newsletter, February 19, 2024). February 19, 2024 by Tom Angell
UncategorizedAlabama Medical Marijuana Could Take Months to Access, Even after Licensing Cases End February 18, 2024 by Marijuana Moment
UncategorizedA Retiring Actor’s Advice for the Marijuana Movement and Industry (Op-Ed). February 18, 2024 by Marijuana Moment
UncategorizedFDA Officials and Experts Discuss Psychedelics Challenges and Promises February 17, 2024 by Kyle Jaeger
UncategorizedNew South Dakota Law Eliminates Workplace Protections for Medical Marijuana Users in Safety-Sensitive jobs February 17, 2024 by Ben Adlin
UncategorizedNew Jersey will’reach and surpass’ $1 billion in Marijuana sales by 2024 even as federal legalization stalls, top state regulator says February 16, 2024 by Kyle Jaeger
UncategorizedNew York State Officials approve marijuana home grow rules and new business licenses amid a ‘rocky start’ for the legal market February 16, 2024 by Kyle Jaeger
UncategorizedDelaware Officials Release Draft Rules for Adult-Use Marijuana as States Prepares for Legalization February 16, 2024 by Kyle Jaeger
